FI862303A - Foerfarande foer framstaellning av cancer motverkande kinazolinderivater. - Google Patents
Foerfarande foer framstaellning av cancer motverkande kinazolinderivater. Download PDFInfo
- Publication number
- FI862303A FI862303A FI862303A FI862303A FI862303A FI 862303 A FI862303 A FI 862303A FI 862303 A FI862303 A FI 862303A FI 862303 A FI862303 A FI 862303A FI 862303 A FI862303 A FI 862303A
- Authority
- FI
- Finland
- Prior art keywords
- group
- heteroatom
- motverkande
- kinazolinderivater
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858513754A GB8513754D0 (en) | 1985-05-31 | 1985-05-31 | Anti-cancer quinazoline derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI862303A0 FI862303A0 (fi) | 1986-05-30 |
| FI862303A true FI862303A (fi) | 1986-12-01 |
Family
ID=10579966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI862303A FI862303A (fi) | 1985-05-31 | 1986-05-30 | Foerfarande foer framstaellning av cancer motverkande kinazolinderivater. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5236927A (pt) |
| EP (1) | EP0204529B1 (pt) |
| JP (1) | JPS61282368A (pt) |
| AT (1) | ATE87621T1 (pt) |
| AU (1) | AU592271B2 (pt) |
| DE (1) | DE3688150T2 (pt) |
| DK (1) | DK255786A (pt) |
| ES (1) | ES8800911A1 (pt) |
| FI (1) | FI862303A (pt) |
| GB (2) | GB8513754D0 (pt) |
| GR (1) | GR861418B (pt) |
| HU (1) | HUT45512A (pt) |
| IL (1) | IL78910A0 (pt) |
| NO (1) | NO862170L (pt) |
| NZ (1) | NZ216363A (pt) |
| PT (1) | PT82682B (pt) |
| ZA (1) | ZA864051B (pt) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607683D0 (en) * | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
| GB8707053D0 (en) * | 1987-03-25 | 1987-04-29 | Ici Plc | Anti-tumour agents |
| US4857530A (en) * | 1987-11-03 | 1989-08-15 | Warner-Lambert Company | Substituted quinazolinones as anticancer agents |
| GB8809978D0 (en) * | 1988-04-27 | 1988-06-02 | Ici Plc | Anti-tumour agents |
| EP0365763A1 (en) * | 1988-09-30 | 1990-05-02 | Agouron Pharmaceuticals, Inc. | Antiproliferative cyclic compounds |
| US5286726A (en) * | 1990-04-12 | 1994-02-15 | The Regents Of The University Of Michigan | Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases |
| GB9013615D0 (en) | 1990-06-19 | 1990-08-08 | Wellcome Found | Pharmaceutical compounds |
| US6762188B1 (en) | 1990-06-19 | 2004-07-13 | Smithkline Beecham Corporation | Pharmaceutically active benzoquinazoline compounds |
| GB9105771D0 (en) * | 1991-03-19 | 1991-05-01 | Cancer Res Inst Royal | Anti-cancer compounds |
| GB9205320D0 (en) * | 1992-03-11 | 1992-04-22 | Ici Plc | Anti-tumour compounds |
| GB9205907D0 (en) * | 1992-03-18 | 1992-04-29 | Cancer Res Inst Royal | Anti-cancer compounds |
| US5430148A (en) * | 1992-03-31 | 1995-07-04 | Agouron Pharmaceuticals, Inc. | Antiproliferative quinazolines |
| GB9223352D0 (en) * | 1992-11-06 | 1992-12-23 | Ici Plc | Tricyclic compounds |
| US7262058B2 (en) * | 2001-03-09 | 2007-08-28 | Nonda Katopodis | Method for determining lipid associated sialoprotein in body fluids |
| KR20050061545A (ko) * | 2002-10-18 | 2005-06-22 | 코닌클리케 필립스 일렉트로닉스 엔.브이. | Ｔｖ-애니타임의 메타데이터 보호를 위한 방법 및 시스템 |
| CA2502302A1 (en) * | 2002-11-04 | 2004-05-21 | Nps Pharmaceuticals, Inc. | Quinazolinone compounds as calcilytics |
| WO2007011618A1 (en) * | 2005-07-15 | 2007-01-25 | Schering Corporation | Quinazoline derivatives useful in cancer treatment |
| CA2615380A1 (en) * | 2005-07-15 | 2007-01-25 | Schering Corporation | Quinazoline derivatives useful in cancer treatment |
| CN101547922B (zh) | 2006-10-04 | 2012-06-20 | 辉瑞产品公司 | 作为钙受体拮抗剂的吡啶并[4,3-d]嘧啶-4(3H)-酮衍生物 |
| CA2966280A1 (en) | 2007-10-26 | 2009-04-30 | The Regents Of The University Of California | Diarylhydantoin compounds |
| HRP20171415T4 (hr) | 2009-06-25 | 2023-03-03 | Alkermes Pharma Ireland Limited | Heterociklični spojevi za liječenje neuroloških i psiholoških poremećaja |
| JP6076740B2 (ja) * | 2010-01-07 | 2017-02-08 | アルカーメス ファーマ アイルランド リミテッド | 第四級アンモニウム塩プロドラッグ |
| EP2585066B1 (en) | 2010-06-24 | 2018-09-26 | Alkermes Pharma Ireland Limited | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| US9034867B2 (en) | 2011-03-18 | 2015-05-19 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising sorbitan esters |
| CA2867137C (en) | 2012-03-19 | 2020-12-08 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising aripiprazole prodrugs and benzyl alcohol |
| JP6219918B2 (ja) | 2012-03-19 | 2017-10-25 | アルカームス ファーマ アイルランド リミテッド | グリセロールエステルを含む医薬組成物 |
| JP6471089B2 (ja) | 2012-03-19 | 2019-02-13 | アルカームス ファーマ アイルランド リミテッド | 脂肪酸エステルを含む医薬組成物 |
| ES2792149T3 (es) | 2012-09-19 | 2020-11-10 | Alkermes Pharma Ireland Ltd | Composiciones farmacéuticas que tienen estabilidad de almacenamiento mejorada |
| MX2016012041A (es) | 2014-03-20 | 2017-01-19 | Alkermes Pharma Ireland Ltd | Formulaciones de aripiprazol que tienen mayores velocidades de inyeccion. |
| JP7384812B2 (ja) | 2018-03-05 | 2023-11-21 | アルカームス ファーマ アイルランド リミテッド | アリピプラゾール投与戦略 |
| WO2024028999A1 (ja) * | 2022-08-03 | 2024-02-08 | Ils株式会社 | Ｎ－［４－メチルアミノベンゾイル］－ｌ－グルタミン酸ジエチルエステルの製造方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1021196A (en) * | 1964-02-20 | 1966-03-02 | Parke Davis & Co | Novel amino acids and means for producing the same |
| US3471498A (en) * | 1967-08-11 | 1969-10-07 | Parke Davis & Co | Certain n-p-((2,4-diamino-6-quinazolinyl)-methyl)benzoylamino acids |
| EP0031237B1 (en) | 1979-12-19 | 1984-10-17 | National Research Development Corporation | Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents |
| GB8607683D0 (en) * | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
-
1985
- 1985-05-31 GB GB858513754A patent/GB8513754D0/en active Pending
-
1986
- 1986-05-26 IL IL78910A patent/IL78910A0/xx unknown
- 1986-05-30 JP JP61125587A patent/JPS61282368A/ja active Pending
- 1986-05-30 EP EP86304148A patent/EP0204529B1/en not_active Expired - Lifetime
- 1986-05-30 HU HU862288A patent/HUT45512A/hu unknown
- 1986-05-30 AU AU58220/86A patent/AU592271B2/en not_active Ceased
- 1986-05-30 PT PT82682A patent/PT82682B/pt not_active IP Right Cessation
- 1986-05-30 DK DK255786A patent/DK255786A/da not_active Application Discontinuation
- 1986-05-30 ES ES555548A patent/ES8800911A1/es not_active Expired
- 1986-05-30 GB GB08613184A patent/GB2175903B/en not_active Expired
- 1986-05-30 NZ NZ216363A patent/NZ216363A/xx unknown
- 1986-05-30 AT AT86304148T patent/ATE87621T1/de not_active IP Right Cessation
- 1986-05-30 ZA ZA864051A patent/ZA864051B/xx unknown
- 1986-05-30 DE DE8686304148T patent/DE3688150T2/de not_active Expired - Fee Related
- 1986-05-30 GR GR861418A patent/GR861418B/el unknown
- 1986-05-30 FI FI862303A patent/FI862303A/fi not_active Application Discontinuation
- 1986-05-30 NO NO862170A patent/NO862170L/no unknown
-
1990
- 1990-12-12 US US07/625,695 patent/US5236927A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK255786D0 (da) | 1986-05-30 |
| EP0204529A2 (en) | 1986-12-10 |
| DE3688150T2 (de) | 1993-07-29 |
| EP0204529B1 (en) | 1993-03-31 |
| GB2175903B (en) | 1988-10-12 |
| ES555548A0 (es) | 1987-12-01 |
| PT82682B (pt) | 1988-03-03 |
| ATE87621T1 (de) | 1993-04-15 |
| IL78910A0 (en) | 1986-09-30 |
| GB8513754D0 (en) | 1985-07-03 |
| DK255786A (da) | 1986-12-01 |
| JPS61282368A (ja) | 1986-12-12 |
| NO862170L (no) | 1986-12-01 |
| NZ216363A (en) | 1989-07-27 |
| DE3688150D1 (de) | 1993-05-06 |
| ZA864051B (en) | 1987-01-28 |
| FI862303A0 (fi) | 1986-05-30 |
| ES8800911A1 (es) | 1987-12-01 |
| HUT45512A (en) | 1988-07-28 |
| GR861418B (en) | 1986-09-26 |
| AU5822086A (en) | 1986-12-04 |
| EP0204529A3 (en) | 1987-11-19 |
| US5236927A (en) | 1993-08-17 |
| PT82682A (en) | 1986-06-01 |
| GB8613184D0 (en) | 1986-07-02 |
| GB2175903A (en) | 1986-12-10 |
| AU592271B2 (en) | 1990-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI862303A0 (fi) | Foerfarande foer framstaellning av cancer motverkande kinazolinderivater. | |
| MX166257B (es) | Composicion de revestimiento que contiene grupos de carbamato de hidroxialquilo | |
| DK345989D0 (da) | Quinolinderivater | |
| DE3772015D1 (de) | Chinolinverbindung. | |
| AR247744A1 (es) | Compuestos organosilano y catalizadores que contienen dichos compuestos | |
| DE69001495D1 (de) | Dioxaphosphorin-verbindungen und damit stabilisierte polyolefin-zusammensetzungen. | |
| MX170732B (es) | Composicion de derivados de succinimida y su uso | |
| ATE142620T1 (de) | 1-alkyl-2-acyl-1,2-disulfonylhydrazine mit antineoplastischer aktivität | |
| DE3688128D1 (de) | Isoindolinderivate und verfahren zu ihrer herstellung. | |
| NO166408C (no) | Propanolderivater. | |
| SU1690242A1 (ru) | Антифидант | |
| SU1266156A1 (ru) | 7-морфолинокумарины в качестве красителей для лазерной техники |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |
Owner name: NATIONAL RESEARCH DEVELOPMENT |